Overlooked for 30 years: a new kid on the block
A team led by Christian Haass and Michael Willem reports in Nature a novel peptide that plays a role in Alzheimer’s disease: The previously overlooked eta-amyloid interferes with neuronal function and may antogonize beta-amyloid – a finding that has implications for ongoing clinical trials. more
On May 21, 2015, the official opening of the new Center for Stroke and Dementia Research was celebrated with an official hand-over of the key.
His discovery changed the view of Alzheimer's which prevailed at that time: β-amyloid is produced by all of us, not only by Alzheimer patients, and could be a potential biomarker and target for therapy.